Search results for N-terminal
![APC Anti-LMO2 antibody [SP51] (N-terminal) Brand Logo](https://file.buyantibody.com/public/brand/20260608/Abcam.jpg "Click to View APC Anti-LMO2 antibody [SP51] (N-terminal) Product Detail")
APC Anti-LMO2 antibody [SP51] (N-terminal), Abcam, AB305914
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human, Mouse
Applications
IHC-P, Target Binding Affinity, Antibody Labelling
Conjugation
APC
APC Anti-LYPD3 antibody [SP250] (N-terminal), Abcam, AB306513
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Applications
Flow Cyt, Antibody Labelling, Target Binding Affinity, IHC-P
Conjugation
APC
APC Anti-Raf1 antibody [EP4969] - N-terminal, Abcam, AB310836
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Host
Rabbit
Reactivity
Human, Mouse, Rat
Applications
Antibody Labelling, Flow Cyt (Intra), ICC/IF, Target Binding Affinity
Conjugation
APC
CDKN2AIP N-Terminal-Like Protein (CDKN2AIPNL) Antibody, Abbexa, abx109637
CDKN2AIP N-terminal-like protein Antibody is a Rabbit Polyclonal antibody against CDKN2AIP N-terminal-like protein.
Host
Rabbit
Reactivity
Human
Applications
ELISA, IHC
Conjugation
Unconjugated
CDKN2AIP N-terminal-like protein Antibody (Biotin), Abbexa, abx105250
CDKN2AIP N-terminal-like protein Antibody (Biotin) is a Rabbit Polyclonal antibody against CDKN2AIP N-terminal-like protein conjugated to Biotin.
Host
Rabbit
Reactivity
Human
Applications
ELISA
Conjugation
Biotin
Anti-VAPA antibody [EPR13589(B)] - N-terminal, Abcam, AB181067
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Applications
WB, IHC-P
Conjugation
Anti-VPS26 antibody [EPR13455(B)] - N-terminal, Abcam, AB180172
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Applications
WB
Conjugation
Anti-WAVE 1 antibody [EPR15021] - N-terminal, Abcam, AB185546
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Applications
Flow Cyt (Intra), WB
Conjugation
Anti-LRP4 antibody [N207/27] - N-terminal, Abcam, AB174637
The clone number has been updated from S207-27 to N207/27, both clone numbers name the same antibody clone.
Host
Mouse
Reactivity
Rat, Human
Applications
WB, ICC/IF
Conjugation
Anti-LRRK2 antibody [N138/6] - N-terminal, Abcam, AB186334
The clone number has been updated from S138-6 to N138/6, both clone numbers name the same antibody clone.
Host
Mouse
Reactivity
Rat, Human
Applications
WB, ICC/IF
Conjugation
Please provide the required information below so that we can quickly source your products.